期刊文献+

川芎嗪静脉滴注致严重低血压1例 被引量:2

下载PDF
导出
作者 张志彬
机构地区 中国人民解放军
出处 《中国药业》 CAS 2002年第12期79-80,共2页 China Pharmaceuticals
  • 引文网络
  • 相关文献

同被引文献20

  • 1舒冰,周重建,马迎辉,王拥军,施杞.中药川芎中有效成分的药理作用研究进展[J].中国药理学通报,2006,22(9):1043-1047. 被引量:249
  • 2Capodanno D, Ministeri M, Cumbo S, et al. Volume to creatinine clearance ratio in patients undergoing coronary angiography with or without percutaneous coronary intervention: implications of varying definitions of contrast induced nephropathy[J]. Catheter Cardiovasc Interv, 2014, 83: 907 912.
  • 3Abe M, Morimoto T, Akao M, et al. Relation of contrast induced nephropathy to long term mortality after percutaneous coronary intervention[J]. Am J Cardiol, 2014, 114: 362 368.
  • 4Kalaiselvan V, Sharma S, Singh GN. Adverse reactions to contrast media: an analysis of spontaneous reports in the database of the pharmacovigilance programme of India[J]. Drug Saf, 2014, 37: 703 710.
  • 5Golshahi J, Nasri H, Gharipour M. Contrast induced nephropathy; A literature review[J]. J Nephropathol, 2014. 3: 51 56.
  • 6Burgess WP, Walker PJ. Mechanisms of contrast induced nephropathy reduction for saline (NaCl) and Sodium bicarbonate(NaHCO3)[J]. Biomed Res Int, 2014: 510385.
  • 7Ivanes F, Isorni MA, Halimi JM, et al. Predictive factors of contrast induced nephropathy in patients undergoing primary coronary angioplasty[J]. Arch Cardiovasc Dis, 2014, 107: 424 432.
  • 8Yang K, Liu W, Ren W, et al. Different interventions in preventing contrast induced nephropathy after percutaneous coronary intervention[J]. Int Urol Nephrol, 2014, 46: 1801 1807.
  • 9池菊芳,郭航远,彭放,杨彪.经皮冠状动脉介入治疗术后长期联合阿司匹林和氯吡格雷抗血小板治疗的安全性评价[J].中国全科医学,2008,11(14):1254-1256. 被引量:8
  • 10曾聪彦,梅全喜.川芎嗪致30例不良反应文献分析[J].中国药房,2008,19(24):1908-1910. 被引量:13

引证文献2

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部